ACHE and dementia: Although we tried to minimise this risk by inclusion of patients with records of prescriptions for drugs only used to treat dementia (acetylcholinesterase inhibitors or memantine hydrochloride), a residual risk of misclassification exists that would reduce the estimated effects towards the null.